EQL Pharma AB (publ)

OM:EQL 株式レポート

時価総額:SEK 1.9b

EQL Pharma 将来の成長

Future 基準チェック /66

EQL Pharma is forecast to grow earnings and revenue by 45.7% and 26.1% per annum respectively. EPS is expected to grow by 45.7% per annum. Return on equity is forecast to be 32.8% in 3 years.

主要情報

45.7%

収益成長率

45.7%

EPS成長率

Healthcare 収益成長34.2%
収益成長率26.1%
将来の株主資本利益率32.8%
アナリストカバレッジ

Low

最終更新日18 Oct 2024

今後の成長に関する最新情報

Recent updates

Market Participants Recognise EQL Pharma AB (publ)'s (STO:EQL) Earnings Pushing Shares 26% Higher

Oct 29
Market Participants Recognise EQL Pharma AB (publ)'s (STO:EQL) Earnings Pushing Shares 26% Higher

EQL Pharma's (STO:EQL) Shareholders Have More To Worry About Than Only Soft Earnings

Aug 22
EQL Pharma's (STO:EQL) Shareholders Have More To Worry About Than Only Soft Earnings

Here's Why EQL Pharma (STO:EQL) Has A Meaningful Debt Burden

Aug 12
Here's Why EQL Pharma (STO:EQL) Has A Meaningful Debt Burden

EQL Pharma AB (publ)'s (NGM:EQL) P/E Is Still On The Mark Following 30% Share Price Bounce

Jun 13
EQL Pharma AB (publ)'s (NGM:EQL) P/E Is Still On The Mark Following 30% Share Price Bounce

EQL Pharma (NGM:EQL) Is Doing The Right Things To Multiply Its Share Price

May 14
EQL Pharma (NGM:EQL) Is Doing The Right Things To Multiply Its Share Price

EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture

Feb 21
EQL Pharma's (NGM:EQL) Weak Earnings May Only Reveal A Part Of The Whole Picture

The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested

Jun 28
The Trend Of High Returns At EQL Pharma (NGM:EQL) Has Us Very Interested

With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case

Apr 28
With EPS Growth And More, EQL Pharma (NGM:EQL) Makes An Interesting Case

EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors

Feb 24
EQL Pharma AB (publ)'s (NGM:EQL) 26% Jump Shows Its Popularity With Investors

EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital

Dec 19
EQL Pharma (NGM:EQL) Is Achieving High Returns On Its Capital

Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?

Jun 29
Does EQL Pharma (NGM:EQL) Deserve A Spot On Your Watchlist?

Is EQL Pharma (NGM:EQL) Using Too Much Debt?

Apr 29
Is EQL Pharma (NGM:EQL) Using Too Much Debt?

We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

Aug 10
We Think EQL Pharma AB (publ)'s (NGM:EQL) CEO Compensation Looks Fair

EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns

Jun 07
EQL Pharma (NGM:EQL) Hasn't Managed To Accelerate Its Returns

If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late

Apr 16
If You Like EPS Growth Then Check Out EQL Pharma (NGM:EQL) Before It's Too Late

How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Mar 11
How Many EQL Pharma AB (publ) (NGM:EQL) Shares Have Insiders Sold, In The Last Year?

Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Feb 21
Are EQL Pharma's (NGM:EQL) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

Feb 03
Is EQL Pharma AB (publ)'s (NGM:EQL) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?

What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation

Jan 16
What We Learned About EQL Pharma's (NGM:EQL) CEO Compensation

Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?

Dec 28
Will the Promising Trends At EQL Pharma (NGM:EQL) Continue?

What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?

Dec 11
What Type Of Shareholders Make Up EQL Pharma AB (publ)'s (NGM:EQL) Share Registry?

EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment

Nov 22
EQL Pharma (NGM:EQL) Has Rewarded Shareholders With An Exceptional 436% Total Return On Their Investment

業績と収益の成長予測

OM:EQL - アナリストの将来予測と過去の財務データ ( )SEK Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/2027640129751151
3/31/20264948747881
3/31/20254296926672
6/30/202429126-86-19N/A
3/31/202426423-78-11N/A
12/31/202324622-4719N/A
9/30/202325628-1112N/A
6/30/202327030-183N/A
3/31/202326031728N/A
12/31/2022403331529N/A
9/30/2022440393451N/A
6/30/2022419364163N/A
3/31/2022410322042N/A
12/31/202123319-649N/A
9/30/20211454-2440N/A
6/30/20211172-66-5N/A
3/31/202117910460N/A
12/31/202017217-1028N/A
9/30/202016316-520N/A
6/30/2020157145065N/A
3/31/2020723-117N/A
12/31/2019682-133N/A
9/30/201958-2-214N/A
6/30/201954-2-128N/A
3/31/201950-2-106N/A
12/31/201843-2110N/A
9/30/2018410N/AN/AN/A
6/30/2018350-22-3N/A
3/31/201832-1N/A-2N/A
12/31/2017301N/A-4N/A
9/30/2017300N/A-11N/A
6/30/2017260N/A-7N/A
3/31/2017240N/A1N/A
12/31/2016314N/A1N/A
9/30/2016295N/A10N/A
6/30/2016346N/A6N/A
3/31/2016357N/A2N/A
12/31/2015294N/A0N/A
9/30/2015261N/A-9N/A
6/30/201521-2N/A-7N/A
3/31/201519-5N/A-11N/A
12/31/201418-9N/A-12N/A
9/30/201419-11N/A-9N/A
6/30/201419-12N/A-8N/A
3/31/201420-11N/A-6N/A
12/31/201322-8N/A-6N/A

アナリストによる今後の成長予測

収入対貯蓄率: EQL's forecast earnings growth (45.7% per year) is above the savings rate (1.1%).

収益対市場: EQL's earnings (45.7% per year) are forecast to grow faster than the Swedish market (15.7% per year).

高成長収益: EQL's earnings are expected to grow significantly over the next 3 years.

収益対市場: EQL's revenue (26.1% per year) is forecast to grow faster than the Swedish market (0.01% per year).

高い収益成長: EQL's revenue (26.1% per year) is forecast to grow faster than 20% per year.


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: EQL's Return on Equity is forecast to be high in 3 years time (32.8%)


成長企業の発掘